2025年7月17日,美国医疗科技公司HeartFlow向美国证券交易委员会(SEC)提交S-1注册文件,计划在纳斯达克上市,股票代码为“HTFL”。此次IPO预计募集资金1亿美元(约合人民币7亿),将用于偿还可转债、推进平台研发、扩展销售体系,并评估潜在并购机会。作为AI在冠心病影像诊断中应用最早、落地最广的代表之一,HeartFlow此次上市不仅是其迈向商业化成熟阶段的重要节点,也反映出以非...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.